Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Stroke

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 116 articles:
HTML format
Text format



Single Articles


    July 2019
  1. HOPEWELL JC, Ibrahim M, Hill M, Shaw PM, et al
    Impact of ADCY9 Genotype on Response to Anacetrapib.
    Circulation. 2019 Jul 23. doi: 10.1161/CIRCULATIONAHA.119.041546.
    PubMed     Text format     Abstract available


    June 2019
  2. JOHNSTON SC, Elm JJ, Easton JD, Farrant M, et al
    Time Course for Benefit and Risk of Clopidogrel and Aspirin after Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial.
    Circulation. 2019 Jun 26. doi: 10.1161/CIRCULATIONAHA.119.040713.
    PubMed     Text format     Abstract available


    March 2019
  3. GROTTA JC
    Interhospital Transfer of Stroke Patients for Endovascular Treatment.
    Circulation. 2019;139:1578-1580.
    PubMed     Text format    


    January 2019
  4. VANHAVERBEKE M, Bogaerts K, Sinnaeve PR, Janssens L, et al
    Prevention of Cardiogenic Shock After Acute Myocardial Infarction.
    Circulation. 2019;139:137-139.
    PubMed     Text format    


    September 2018
  5. GEORGAKIS MK, Gill D, Rannikmae K, Traylor M, et al
    Genetically Determined Levels of Circulating Cytokines and Risk of Stroke: Role of Monocyte Chemoattractant Protein-1.
    Circulation. 2018 Sep 26. doi: 10.1161/CIRCULATIONAHA.118.035905.
    PubMed     Text format     Abstract available


  6. MENON BK, Xu H, Cox M, Saver JL, et al
    Components and Trends in Door to Treatment Times for Endovascular Therapy in GWTG-Stroke Hospitals.
    Circulation. 2018 Sep 21. doi: 10.1161/CIRCULATIONAHA.118.036701.
    PubMed     Text format     Abstract available


    July 2018
  7. AL SULTAN AS, Hill MD
    Acute Ischemic Stroke Biology Demands Fast Treatment.
    Circulation. 2018;138:241-243.
    PubMed     Text format    


    June 2018
  8. BOHULA EA, Wiviott SD, Giugliano RP, Park JG, et al
    Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
    Circulation. 2018;137:2662-2663.
    PubMed     Text format    


  9. KOH KK
    Letter by Koh Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2660-2661.
    PubMed     Text format    


  10. CORDERO A, Bertomeu-Gonzalez V, Rodriguez-Manero M
    Letter by Cordero et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2658-2659.
    PubMed     Text format    


  11. THOMOPOULOS C, Michalopoulou H
    Letter by Thomopoulos and Michalopoulou Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Tr
    Circulation. 2018;137:2656-2657.
    PubMed     Text format    


  12. DEL PINTO R, Ferri C, Borghi C
    Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2654-2655.
    PubMed     Text format    


    May 2018
  13. MENDY A
    Association of Urinary Nitrate With Lower Prevalence of Hypertension and Stroke and With Reduced Risk of Cardiovascular Mortality.
    Circulation. 2018;137:2295-2297.
    PubMed     Text format    


    April 2018
  14. CHEN LY, Chung MK, Allen LA, Ezekowitz M, et al
    Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Apr 16. pii: CIR.0000000000000568.
    PubMed     Text format     Abstract available


  15. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Response by Lau et al to Letters Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1534-1535.
    PubMed     Text format    


  16. SPARTALIS M, Tzatzaki E, Spartalis E
    Letter by Spartalis et al Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1528-1529.
    PubMed     Text format    


    March 2018
  17. MULDER MJHL, Jansen IGH, Goldhoorn RB, Venema E, et al
    Time to Endovascular Treatment and Outcome in Acute Ischemic Stroke: MR CLEAN Registry Results.
    Circulation. 2018 Mar 26. pii: CIRCULATIONAHA.117.032600.
    PubMed     Text format     Abstract available


    February 2018
  18. HICKS KA, Mahaffey KW, Mehran R, Nissen SE, et al
    2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
    Circulation. 2018;137:961-972.
    PubMed     Text format     Abstract available


  19. NIELSEN PB, Skjoth F, Overvad TF, Larsen TB, et al
    Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?
    Circulation. 2018;137:832-840.
    PubMed     Text format     Abstract available



  20. Correction to: Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Pr
    Circulation. 2018;137:e29.
    PubMed     Text format    


    January 2018
  21. BENJAMIN EJ, Virani SS, Callaway CW, Chang AR, et al
    Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.
    Circulation. 2018 Jan 31. pii: CIR.0000000000000558.
    PubMed     Text format    


  22. ALBERTS MJ, Ollenschleger MD, Nouh A
    DAWN of a New Era for Stroke Treatment: Implications of the DAWN Study for Acute Stroke Care and Stroke Systems of Care.
    Circulation. 2018 Jan 18. pii: CIRCULATIONAHA.118.033579.
    PubMed     Text format     Abstract available


  23. GOLD MR
    Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?
    Circulation. 2018;137:217-218.
    PubMed     Text format    


  24. EMDIN CA, Khera AV, Klarin D, Natarajan P, et al
    Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling.
    Circulation. 2018;137:222-232.
    PubMed     Text format     Abstract available


  25. VEDEL AG, Holmgaard F, Rasmussen LS, Langkilde A, et al
    High-Target vs Low-Target Blood Pressure Management During Cardiopulmonary Bypass to Prevent Cerebral Injury in Cardiac Surgery Patients - A Randomized Controlled Trial.
    Circulation. 2018 Jan 16. pii: CIRCULATIONAHA.117.030308.
    PubMed     Text format     Abstract available


  26. JOLLY SS, Gao P, Cairns JA, Yusuf S, et al
    Risks of Overinterpreting Interim Data: Lessons From the TOTAL Trial (Thrombectomy With PCI Versus PCI Alone in Patients With STEMI).
    Circulation. 2018;137:206-209.
    PubMed     Text format    


  27. BARANCHUK A, Torner P, de Luna AB
    Bayes Syndrome: What Is It?
    Circulation. 2018;137:200-202.
    PubMed     Text format    


  28. FISHER M, Hill JA
    Ischemic Stroke Mandates Cross-Disciplinary Collaboration.
    Circulation. 2018;137:103-105.
    PubMed     Text format    


  29. LEE JZ, Ling J, Diehl NN, Hodge DO, et al
    Mortality and Cerebrovascular Events After Heart Rhythm Disorder Management Procedures.
    Circulation. 2018;137:24-33.
    PubMed     Text format     Abstract available


    December 2017
  30. NTAIOS G, Hart RG
    Embolic Stroke.
    Circulation. 2017;136:2403-2405.
    PubMed     Text format    


  31. GOLDSTONE AB, Chiu P, Baiocchi M, Wang H, et al
    Second Arterial versus Venous Conduits for Multi-Vessel Coronary Artery Bypass Surgery in California.
    Circulation. 2017 Dec 14. pii: CIRCULATIONAHA.117.030959.
    PubMed     Text format     Abstract available


  32. CAMPBELL BCV, Donnan GA, Davis SM
    Optimizing Systems of Care for Endovascular Thrombectomy in Ischemic Stroke: Drip and Ship Versus Mothership.
    Circulation. 2017;136:2322-2324.
    PubMed     Text format    


    November 2017
  33. MEFFORD MT, Rosenson RS, Cushman M, Farkouh ME, et al
    PCSK9 Variants, LDL-Cholesterol, and Neurocognitive Impairment: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Circulation. 2017 Nov 16. pii: CIRCULATIONAHA.117.029785.
    PubMed     Text format     Abstract available


  34. KHERA R, Hong JC, Saxena A, Arrieta A, et al
    Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.030128.
    PubMed     Text format     Abstract available


  35. BENNAGHMOUCH N, de Veer AJWM, Bode K, Mahmoodi BK, et al
    The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
    Circulation. 2017 Nov 3. pii: CIRCULATIONAHA.117.028513.
    PubMed     Text format     Abstract available


    October 2017
  36. YAGHI S, Furie KL, Viscoli CM, Kamel H, et al
    Pioglitazone Prevents Stroke in Patients with a Recent TIA or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial.
    Circulation. 2017 Oct 30. pii: CIRCULATIONAHA.117.030458.
    PubMed     Text format     Abstract available


  37. YOUNG LH, Viscoli CM, Inzucchi SE, Kernan WN, et al
    Response by Young et al to Letters Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".
    Circulation. 2017;136:1567-1568.
    PubMed     Text format    


  38. JIN-SHAN H, Xue-Bin L
    Letter by Jin-Shan and Xue-Bin Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".
    Circulation. 2017;136:1565-1566.
    PubMed     Text format    


  39. MUSSO G, Cassader M, Gambino R
    Letter by Musso et al Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".
    Circulation. 2017;136:1563-1564.
    PubMed     Text format    


  40. SUNDBOLL J, Hovath-Puho E, Adelborg K, Schmidt M, et al
    Higher Risk of Vascular Dementia in Myocardial Infarction Survivors.
    Circulation. 2017 Oct 12. pii: CIRCULATIONAHA.117.029127.
    PubMed     Text format     Abstract available


  41. SMITH EE, Saver JL, Cox M, Liang L, et al
    Increase in Endovascular Therapy in Get With The Guidelines-Stroke After The Publication of Pivotal Trials.
    Circulation. 2017 Oct 5. pii: CIRCULATIONAHA.117.031097.
    PubMed     Text format     Abstract available


    September 2017
  42. BOHULA EA, Wiviott SD, Giugliano RP, Blazing MA, et al
    Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT.
    Circulation. 2017 Sep 30. pii: CIRCULATIONAHA.117.029095.
    PubMed     Text format     Abstract available


  43. FROEHLER MT, Saver JL, Zaidat OO, Jahan R, et al
    Interhospital Transfer Prior to Thrombectomy is Associated with Delayed Treatment and Worse Outcome in the STRATIS Registry.
    Circulation. 2017 Sep 24. pii: CIRCULATIONAHA.117.028920.
    PubMed     Text format     Abstract available


    August 2017
  44. ARMSTRONG PW, Welsh RC
    Recalibrating Reperfusion Waypoints.
    Circulation. 2017 Aug 27. pii: CIRCULATIONAHA.117.030869.
    PubMed     Text format     Abstract available


  45. PU J, Ding S, Ge H, Han Y, et al
    Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Ac
    Circulation. 2017 Aug 27. pii: CIRCULATIONAHA.117.030582.
    PubMed     Text format     Abstract available


  46. HOPKINS LN, Holmes DR Jr
    Response by Hopkins and Holmes to Letter Regarding Article, "Public Health Urgency Created by the Success of Mechanical Thrombectomy Studies in Stroke".
    Circulation. 2017;136:781-782.
    PubMed     Text format    



  47. Letter by the Society of NeuroInterventional Surgery, the Cerebrovascular Section of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons, and the Society of Vascular and Interventional Neurology Regarding Articl
    Circulation. 2017;136:779-780.
    PubMed     Text format    


  48. KALMAN JM, Sanders P, Rosso R, Calkins H, et al
    Should We Perform Catheter Ablation for Asymptomatic Atrial Fibrillation?
    Circulation. 2017;136:490-499.
    PubMed     Text format     Abstract available


    July 2017
  49. HELLER DJ, Coxson PG, Penko J, Pletcher MJ, et al
    Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027067.
    PubMed     Text format     Abstract available


  50. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
    PubMed     Text format     Abstract available


    June 2017
  51. EASTON JD, Aunes M, Albers GW, Amarenco P, et al
    Risk for Major Bleeding in Patients Receiving Ticagrelor Compared with Aspirin After TIA or Acute Ischemic Stroke in the SOCRATES Study.
    Circulation. 2017 Jun 27. pii: CIRCULATIONAHA.117.028566.
    PubMed     Text format     Abstract available


  52. BIVARD A, Muir K, Parsons M
    Response by Bivard et al to Letter Regarding Article, "Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials".
    Circulation. 2017;135:e1141-e1142.
    PubMed     Text format    


  53. ROOZENBEEK B, Dippel DWJ, Lingsma HF
    Letter by Roozenbeek et al Regarding Article, "Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials".
    Circulation. 2017;135:e1139-e1140.
    PubMed     Text format    


  54. FLEVARIS P, Khan SS, Eren M, Schuldt AJ, et al
    PAI-1 Controls Cardiomyocyte TGF-beta and Cardiac Fibrosis.
    Circulation. 2017 Jun 6. pii: CIRCULATIONAHA.117.028145.
    PubMed     Text format     Abstract available


    May 2017
  55. JOLLY SS, James S, Dzavik V, Cairns JA, et al
    Response by Jolly et al to Letters Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1103-e1104.
    PubMed     Text format    


  56. SHAH R
    Letter by Shah Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1101-e1102.
    PubMed     Text format    


  57. JURADO-ROMAN A, Sanchez-Perez I, Lozano-Ruiz-Poveda F
    Letter by Jurado-Roman et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1099-e1100.
    PubMed     Text format    


  58. KARAMASIS GV, Davies JR, Clesham GJ
    Letter by Karamasis et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1097-e1098.
    PubMed     Text format    


  59. DALE C, Fatemifar G, Palmer T, White J, et al
    Causal Associations of Adiposity and Body Fat Distribution with Coronary Heart Disease, Stroke Subtypes and Type 2 Diabetes: A Mendelian Randomization Analysis.
    Circulation. 2017 May 12. pii: CIRCULATIONAHA.116.026560.
    PubMed     Text format     Abstract available


  60. MARTINEZ DE LIZARRONDO S, Gakuba C, Herbig BA, Repesse Y, et al
    Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi.
    Circulation. 2017 May 9. pii: CIRCULATIONAHA.117.027290.
    PubMed     Text format     Abstract available


  61. FREEDMAN B, Camm J, Calkins H, Healey JS, et al
    Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.
    Circulation. 2017;135:1851-1867.
    PubMed     Text format     Abstract available


    April 2017
  62. URIEL N, Colombo PC, Cleveland JC, Long JW, et al
    Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Circulation. 2017 Apr 6. pii: CIRCULATIONAHA.117.028303.
    PubMed     Text format     Abstract available


  63. HUNTER AL, Shah AS, Langrish JP, Raftis JB, et al
    Fire Simulation and Cardiovascular Health in Firefighters.
    Circulation. 2017;135:1284-1295.
    PubMed     Text format     Abstract available


    March 2017
  64. HOPKINS LN, Holmes DR Jr
    Public Health Urgency Created by the Success of Mechanical Thrombectomy Studies in Stroke.
    Circulation. 2017;135:1188-1190.
    PubMed     Text format    


  65. BRIGHT CJ, Hawkins MM, Guha J, Henson KE, et al
    Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study).
    Circulation. 2017;135:1194-1210.
    PubMed     Text format     Abstract available


  66. WENDLER O, Schymik G, Treede H, Baumgartner H, et al
    SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve.
    Circulation. 2017;135:1123-1132.
    PubMed     Text format     Abstract available


  67. SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
    Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
    PubMed     Text format     Abstract available


    February 2017
  68. CAVENDER MA, White WB, Jarolim P, Bakris GL, et al
    Serial Measurement of High Sensitivity Troponin I and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus in the EXAMINE Trial.
    Circulation. 2017 Feb 28. pii: CIRCULATIONAHA.116.024632.
    PubMed     Text format     Abstract available


  69. YOUNG LH, Viscoli CM, Curtis JP, Inzucchi SE, et al
    Cardiac Outcomes After Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance Without Diabetes.
    Circulation. 2017 Feb 28. pii: CIRCULATIONAHA.116.024863.
    PubMed     Text format     Abstract available


  70. CARNICELLI AP, De Caterina R, Halperin JL, Renda G, et al
    Edoxaban for the Prevention of Thromboembolism in Patients with AtrialFibrillation and Bioprosthetic Valves.
    Circulation. 2017 Feb 16. pii: CIRCULATIONAHA.116.026714.
    PubMed     Text format     Abstract available


  71. DUFOUIL C, Beiser AS, McClure LA, Wolf PA, et al
    A Revised Framingham Stroke Risk Profile to Reflect Temporal Trends.
    Circulation. 2017 Feb 3. pii: CIRCULATIONAHA.115.021275.
    PubMed     Text format     Abstract available


    January 2017
  72. XIAN Y, Federspiel JJ, Hernandez AF, Laskowitz D, et al
    Use of Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Before Stroke.
    Circulation. 2017 Jan 24. pii: CIRCULATIONAHA.116.023940.
    PubMed     Text format     Abstract available


  73. OVBIAGELE B, Wang J, Johnston SC, Wang A, et al
    Effect of Clopidogrel by Smoking Status on Secondary Stroke Prevention.
    Circulation. 2017;135:315-316.
    PubMed     Text format    


  74. ALBERTS MJ
    Stroke Treatment With Intravenous Tissue-Type Plasminogen Activator: More Proof That Time Is Brain.
    Circulation. 2017;135:140-142.
    PubMed     Text format    


  75. WANG W, Jiang B, Sun H, Ru X, et al
    Prevalence, Incidence and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480,687 Adults.
    Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.025250.
    PubMed     Text format     Abstract available


    December 2016
  76. SINGH S, Houng AK, Reed GL
    Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and alpha2-Antiplasmin Inactivation.
    Circulation. 2016 Dec 27. pii: CIRCULATIONAHA.116.024421.
    PubMed     Text format     Abstract available


  77. SCHWAMM LH, Chumbler N, Brown E, Fonarow GC, et al
    Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association.
    Circulation. 2016 Dec 20. pii: CIR.0000000000000475.
    PubMed     Text format     Abstract available


  78. BIVARD A, Huang X, McElduff P, Levi CR, et al
    The Impact of CT Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke. Analysis of Two Randomized Controlled Trials.
    Circulation. 2016 Dec 13. pii: CIRCULATIONAHA.116.022582.
    PubMed     Text format     Abstract available


  79. JOLLY SS, James SK, Dzavik V, Cairns JA, et al
    Thrombus Aspiration in ST Elevation Myocardial Infarction: An Individual Patient Meta-analysis.
    Circulation. 2016 Dec 9. pii: CIRCULATIONAHA.116.025371.
    PubMed     Text format     Abstract available


    November 2016
  80. MELDUNI RM, Schaff HV, Lee HC, Gersh BJ, et al
    Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score Matched Analysis of 10,633 Patients.
    Circulation. 2016 Nov 30. pii: CIRCULATIONAHA.116.021952.
    PubMed     Text format     Abstract available


  81. GIBSON CM, Chi G, Halaby R, Korjian S, et al
    Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).
    Circulation. 2016 Nov 14. pii: CIRCULATIONAHA.116.025427.
    PubMed     Text format     Abstract available


  82. MENON BK, Hill MD, Goyal M
    Response by Menon et al to Letter Regarding Article, "Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial".
    Circulation. 2016;134:e406-e407.
    PubMed     Text format    


  83. VENEMA E, Lingsma HF, Dippel DW
    Letter by Venema et al Regarding Article, "Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial".
    Circulation. 2016;134:e404-e405.
    PubMed     Text format    


  84. ZUHLKE L, Karthikeyan G, Engel ME, Rangarajan S, et al
    Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study).
    Circulation. 2016;134:1456-1466.
    PubMed     Text format     Abstract available


  85. KIM JT, Fonarow GC, Smith EE, Reeves MJ, et al
    Treatment with TPA in the "Golden Hour" and the Shape of the 4.5 Hour Time-Benefit Curve in the National US Get With The Guidelines-Stroke Population.
    Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.023336.
    PubMed     Text format     Abstract available


  86. PAN Y, Chen W, Xu Y, Yi X, et al
    Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-analysis.
    Circulation. 2016 Nov 2. pii: CIRCULATIONAHA.116.024913.
    PubMed     Text format     Abstract available


  87. HALPERIN JL, Savino JA 3rd
    Response by Halperin and Savino to Letter Regarding Article, "Should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End
    Circulation. 2016;134:e391-e392.
    PubMed     Text format    


  88. NIELSEN PB, Lip GY
    Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke".
    Circulation. 2016;134:e389-e390.
    PubMed     Text format    


  89. ASINGER RW, Shroff GR, Herzog CA
    Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patie
    Circulation. 2016;134:e387-e388.
    PubMed     Text format    


    October 2016
  90. QUINN GR, Severdija ON, Chang Y, Singer DE, et al
    Wide Variation in Reported Rates of Stroke Across Cohorts of Patients with Atrial Fibrillation.
    Circulation. 2016 Oct 31. pii: CIRCULATIONAHA.116.024057.
    PubMed     Text format     Abstract available


  91. YANAGAWA B, Pettersson GB, Habib G, Ruel M, et al
    Surgical Management of Infective Endocarditis Complicated by Embolic Stroke: Practical Recommendations for Clinicians.
    Circulation. 2016;134:1280-1292.
    PubMed     Text format     Abstract available


    September 2016
  92. KAASENBROOD L, Boekholdt SM, van der Graaf Y, Ray KK, et al
    Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population.
    Circulation. 2016 Sep 28. pii: CIRCULATIONAHA.116.021314.
    PubMed     Text format     Abstract available


  93. SEIDELMANN SB, Claggett B, Bravo PE, Gupta A, et al
    Retinal Vessel Calibers in Predicting Long-term Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study.
    Circulation. 2016 Sep 28. pii: CIRCULATIONAHA.116.023425.
    PubMed     Text format     Abstract available


  94. CHAO TF, Liu CJ, Liao JN, Wang KL, et al
    Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e230-1.
    PubMed     Text format    


  95. YANG X, An R, Xu Y
    Letter by Yang et al Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e228-9.
    PubMed     Text format    


  96. CHAN PH, Siu CW
    Letter by Chan and Siu Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e226-7.
    PubMed     Text format    


  97. LONN EM, Yusuf S
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mmHg Target?: An Antagonist View from HOPE-3.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023264.
    PubMed     Text format     Abstract available


    August 2016
  98. BONACA MP, Goto S, Bhatt DL, Steg PG, et al
    Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-T
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.024637.
    PubMed     Text format     Abstract available


  99. OLDGREN J, Hijazi Z, Lindback J, Alexander JH, et al
    Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
    Circulation. 2016 Aug 28. pii: CIRCULATIONAHA.116.022802.
    PubMed     Text format     Abstract available


  100. BRAUN LT, Grady KL, Kutner JS, Adler E, et al
    Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association.
    Circulation. 2016 Aug 8. pii: CIR.0000000000000438.
    PubMed     Text format     Abstract available


  101. LIP GY
    Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring".
    Circulation. 2016;134:e30-1.
    PubMed     Text format    


    July 2016
  102. PERALTA CA, McClure LA, Scherzer R, Odden MC, et al
    Response by Peralta et al to Letter Regarding Article, "Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Stroke
    Circulation. 2016;134:e26-7.
    PubMed     Text format    


  103. MEZUE K, Puri R, Rangaswami J
    Letter by Mezue et al Regarding Article, "Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Rando
    Circulation. 2016;134:e24-5.
    PubMed     Text format    


  104. HE VY, Condon JR, Ralph AP, Zhao Y, et al
    Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.
    Circulation. 2016;134:222-32.
    PubMed     Text format     Abstract available


  105. PICCINI JP, Hellkamp AS, Washam JB, Becker RC, et al
    Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e7-8.
    PubMed     Text format    


  106. IMPRIALOS K, Boutari C, Stavropoulos K
    Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e5-6.
    PubMed     Text format    


  107. BOUATOU Y, El Biali M, Samer CF
    Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e3-4.
    PubMed     Text format    


  108. HERRMANN HC, Thourani VH, Kodali SK, Makkar RR, et al
    One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Circulation. 2016;134:130-40.
    PubMed     Text format     Abstract available


  109. HIJAZI Z, Wallentin L
    Renal Function in Atrial Fibrillation: A Multifaceted Dilemma.
    Circulation. 2016;134:48-51.
    PubMed     Text format    


  110. FORDYCE CB, Hellkamp AS, Lokhnygina Y, Lindner SM, et al
    On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.
    Circulation. 2016;134:37-47.
    PubMed     Text format     Abstract available


    June 2016
  111. MENON BK, Sajobi TT, Zhang Y, Rempel JL, et al
    Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial.
    Circulation. 2016;133:2279-86.
    PubMed     Text format     Abstract available


    May 2016
  112. SACCO RL, Roth GA, Reddy KS, Arnett DK, et al
    The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.
    Circulation. 2016 May 9. pii: CIR.0000000000000395.
    PubMed     Text format     Abstract available


  113. KEHREL BE, Fender AC
    Resolving Thromboinflammation in the Brain After Ischemic Stroke?
    Circulation. 2016 May 6. pii: CIRCULATIONAHA.116.022858.
    PubMed     Text format     Abstract available


  114. VITAL SA, Becker F, Holloway PM, Russell J, et al
    Fpr2/ALX Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.
    Circulation. 2016 May 6. pii: CIRCULATIONAHA.115.020633.
    PubMed     Text format     Abstract available


  115. NAYOR M, Vasan RS
    Recent Update to the US Cholesterol Treatment Guidelines: A Comparison With International Guidelines.
    Circulation. 2016;133:1795-806.
    PubMed     Text format     Abstract available


    March 2016
  116. CHAO TF, Liu CJ, Liao JN, Wang KL, et al
    The Use of Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients with History of Intra-Cranial Hemorrhage.
    Circulation. 2016 Mar 11. pii: CIRCULATIONAHA.115.019794.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: